![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
Tools
Tools
Preview |
PDF (Original Article)
- Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
4MB |
![[thumbnail of Supporting Information]](https://edoc.mdc-berlin.de/style/images/fileicons/other.png) |
Other (Supporting Information)
11MB |
| Item Type: | Article |
|---|---|
| Title: | Specific nanoprobe design for MRI: targeting laminin in the blood-brain barrier to follow alteration due to neuroinflammation |
| Creators Name: | Zapata-Acevedo, J.F., Losada-Barragán, M., Osma, J.F., Cruz, J.C., Reiber, A., Petry, K.G., Caillard, A., Sauldubois, A., Llamosa Pérez, D., Morillo Zárate, A.J., Muñoz, S.B., Daza Moreno, A., Silva, R.V., Infante-Duarte, C., Chamorro-Coral, W., González-Reyes, R.E. and Vargas-Sánchez, K. |
| Abstract: | Chronic neuroinflammation is characterized by increased blood-brain barrier (BBB) permeability, leading to molecular changes in the central nervous system that can be explored with biomarkers of active neuroinflammatory processes. Magnetic resonance imaging (MRI) has contributed to detecting lesions and permeability of the BBB. Ultra-small superparamagnetic particles of iron oxide (USPIO) are used as contrast agents to improve MRI observations. Therefore, we validate the interaction of peptide-88 with laminin, vectorized on USPIO, to explore BBB molecular alterations occurring during neuroinflammation as a potential tool for use in MRI. The specific labeling of NPS-P88 was verified in endothelial cells (hCMEC/D3) and astrocytes (T98G) under inflammation induced by interleukin 1β (IL-1β) for 3 and 24 hours. IL-1β for 3 hours in hCMEC/D3 cells increased their co-localization with NPS-P88, compared with controls. At 24 hours, no significant differences were observed between groups. In T98G cells, NPS-P88 showed similar nonspecific labeling among treatments. These results indicate that NPS-P88 has a higher affinity towards brain endothelial cells than astrocytes under inflammation. This affinity decreases over time with reduced laminin expression. In vivo results suggest that following a 30-minute post-injection, there is an increased presence of NPS-P88 in the blood and brain, diminishing over time. Lastly, EAE animals displayed a significant accumulation of NPS-P88 in MRI, primarily in the cortex, attributed to inflammation and disruption of the BBB. Altogether, these results revealed NPS-P88 as a biomarker to evaluate changes in the BBB due to neuroinflammation by MRI in biological models targeting laminin. |
| Keywords: | Blood-Brain Barrier, Endothelial Cells, Inflammation, Laminin, Magnetic Resonance Imaging, Neuroinflammatory Diseasee, Animals |
| Source: | PLoS ONE |
| ISSN: | 1932-6203 |
| Publisher: | Public Library of Science |
| Volume: | 19 |
| Number: | 4 |
| Page Range: | e0302031 |
| Date: | 11 April 2024 |
| Official Publication: | https://doi.org/10.1371/journal.pone.0302031 |
| PubMed: | View item in PubMed |
Repository Staff Only: item control page
